T-0156 is a potent and selective phosphodiesterase type 5 ( PDE5 ) inhibitor. T-0156 specifically inhibits the hydrolysis of cyclic guanosine monophosphate (cGMP) by PDE5 in a competitive manner ( IC 50 =0.23 nM). T-0156 inhibits PDE6 (IC 50 =56 nM) and has low potencies against PDE1 , PDE2 , PDE3 , and PDE4 (IC 50 >10 μM). T-0156 enhances the nitric oxide (NO)/cGMP pathway.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Phosphodiesterase (PDE)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.